SIM1 Inhibitors
Chemical inhibitors of SIM1 can impede the protein's function through various mechanisms by targeting distinct cellular pathways. Rapamycin, for instance, binds to mTOR in complex with FKBP12, leading to the inhibition of the mTOR signaling pathway. Since mTOR has a significant role in energy balance and feeding behavior, its inhibition can suppress SIM1 activity, which is also implicated in these physiological processes. Similarly, LY294002, a PI3K inhibitor, disrupts AKT phosphorylation, which is crucial for energy homeostasis, thus negatively affecting SIM1 activity. PD98059, which targets MEK in the MAPK pathway, can lower SIM1 activity due to the pathway's involvement in energy balance regulation. Chelerythrine's inhibition of PKC, a kinase that contributes to stress and energy balance signaling, can also lead to a decrease in SIM1 activity. The AMPK pathway, a cellular energy gauge, can be inhibited by chemicals like Dorsomorphin and BML-275, and this inhibition is another means to reduce the activity of SIM1, as AMPK can influence physiological responses where SIM1 has a role.
Additionally, GW9662 antagonizes PPARγ, affecting energy storage and balance, which can in turn decrease SIM1 activity involved in energy homeostasis. Y-27632, a ROCK inhibitor, disrupts actin cytoskeleton organization, indirectly affecting SIM1 due to the cytoskeleton's role in cellular signaling and balance. AG-490, a JAK2 inhibitor, can reduce STAT3 phosphorylation and leptin signaling, which is relevant to SIM1's function in energy regulation. SP600125 inhibits JNK, which plays a part in insulin signaling, and this inhibition can lead to reduced SIM1 activity, considering the protein's involvement in this pathway.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin forms a complex with FKBP12, which then binds to and inhibits mTOR (mechanistic target of rapamycin). Given mTOR's role in energy balance and feeding behavior, inhibition of this pathway can suppress SIM1 activity, as SIM1 is implicated in these physiological processes. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
WZB117 inhibits GLUT1, a glucose transporter, leading to decreased glucose uptake. This reduction in glucose can lead to a decrease in energy levels within the cell, which is a signal that can suppress SIM1 activity as SIM1 is responsive to energy balance. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK, a kinase involved in stress response pathways. The inhibition of p38 MAPK can alter the cellular stress response, which in turn, can inhibit SIM1 activity due to its role in homeostatic regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which reduces AKT phosphorylation and downstream signaling. Since PI3K/AKT signaling is implicated in the regulation of energy homeostasis, inhibiting this pathway can negatively affect SIM1 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which acts upstream of ERK in the MAPK signaling pathway. Inhibition of this pathway can reduce SIM1 activity, as ERK has been shown to influence energy balance and homeostasis, where SIM1 is a key player. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Dorsomorphin inhibits AMPK, which is involved in sensing cellular energy status. Inhibition of AMPK can decrease the activity of SIM1 since AMPK modulation can influence energy balance and associated physiological responses involving SIM1. | ||||||
GW 9662 | 22978-25-2 | sc-202641 | 5 mg | $70.00 | 30 | |
GW9662 is a PPARγ antagonist. By inhibiting PPARγ, adipogenesis is reduced, which affects energy storage and balance, therefore potentially decreasing SIM1 activity due to its role in energy homeostasis. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Chelerythrine is a potent inhibitor of PKC, a kinase involved in various signaling pathways including those related to stress and energy balance. Inhibition of PKC can lead to decreased SIM1 activity due to its regulatory role in these processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, and by inhibiting ROCK, the actin cytoskeleton organization is affected. Since cell shape and motility are linked to cellular signaling and homeostasis, this can indirectly inhibit SIM1 activity. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
AG-490 is a JAK2 inhibitor, and inhibiting JAK2 can reduce STAT3 phosphorylation, which is involved in leptin signaling. Since SIM1 is part of leptin signaling related to energy homeostasis, this can inhibit SIM1 activity. | ||||||